669 related articles for article (PubMed ID: 27226718)
1. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
Toth PP
Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
Kohan AB
Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):119-25. PubMed ID: 25692924
[TBL] [Abstract][Full Text] [Related]
4. Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice.
Zhang Y; He W; He C; Wan J; Lin X; Zheng X; Li L; Li X; Yang X; Yu B; Xian X; Zhu Y; Wang Y; Liu G; Lu N
Cell Death Dis; 2019 Sep; 10(10):728. PubMed ID: 31570698
[TBL] [Abstract][Full Text] [Related]
5. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
Tenenbaum A; Klempfner R; Fisman EZ
Cardiovasc Diabetol; 2014 Dec; 13():159. PubMed ID: 25471221
[TBL] [Abstract][Full Text] [Related]
6. Demystifying the management of hypertriglyceridaemia.
Watts GF; Ooi EM; Chan DC
Nat Rev Cardiol; 2013 Nov; 10(11):648-61. PubMed ID: 24060958
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
[TBL] [Abstract][Full Text] [Related]
8. Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.
Saeed A; Feofanova EV; Yu B; Sun W; Virani SS; Nambi V; Coresh J; Guild CS; Boerwinkle E; Ballantyne CM; Hoogeveen RC
J Am Coll Cardiol; 2018 Jul; 72(2):156-169. PubMed ID: 29976289
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment.
Wieczorek E; Ćwiklińska A; Jankowski M
Clin Chem Lab Med; 2022 Jul; 60(8):1145-1159. PubMed ID: 35687325
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
Chapman MJ; Ginsberg HN; Amarenco P; Andreotti F; Borén J; Catapano AL; Descamps OS; Fisher E; Kovanen PT; Kuivenhoven JA; Lesnik P; Masana L; Nordestgaard BG; Ray KK; Reiner Z; Taskinen MR; Tokgözoglu L; Tybjærg-Hansen A; Watts GF;
Eur Heart J; 2011 Jun; 32(11):1345-61. PubMed ID: 21531743
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.
Sascău R; Clement A; Radu R; Prisacariu C; Stătescu C
Nutrients; 2021 May; 13(6):. PubMed ID: 34067469
[TBL] [Abstract][Full Text] [Related]
12. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride-rich lipoproteins and cardiovascular diseases.
Xu D; Xie L; Cheng C; Xue F; Sun C
Front Endocrinol (Lausanne); 2024; 15():1409653. PubMed ID: 38883601
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Dallinga-Thie GM; Kroon J; Borén J; Chapman MJ
Curr Cardiol Rep; 2016 Jul; 18(7):67. PubMed ID: 27216847
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
[TBL] [Abstract][Full Text] [Related]
16. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
17. Triglycerides: How to Manage Patients with Elevated Triglycerides and When to Refer?
Bazarbashi N; Miller M
Med Clin North Am; 2022 Mar; 106(2):299-312. PubMed ID: 35227432
[TBL] [Abstract][Full Text] [Related]
18. Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort.
Kayıkçıoğlu M; Shahbazova S; İbrahimov F; Can LH
Turk Kardiyol Dern Ars; 2020 Jun; 48(4):359-367. PubMed ID: 32519982
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
[TBL] [Abstract][Full Text] [Related]
20. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
